Skip to content

    Insecticides (India) Q1 FY27 earnings call

    INSECTICID
    Chemicals·17 Aug 2026
    Management Summary

    Insecticides (India) Limited reported a challenging Q1 FY27 with revenue degrowth of 12% to INR612 crores, primarily due to an unusual agricultural season marked by delayed monsoons. Despite this, gross profit percentage improved to 31.6%, driven by a higher contribution from premium products (64% of B2C sales). The company is progressing with its Sotanala expansion, targeting INR200 crores investment, and expects a recovery in demand and performance from Q2 onwards.

    Highlights

    5
    • Gross profit percentage increased from 29% to 31.6% despite revenue degrowth.

    • Premium product sales increased from 58% (Q1 FY26) to 64% (Q1 FY27) of total B2C contribution.

    • Newly launched products (Granuvia & Spinoace) generated INR5.50 crores in Q1 FY27, with Granuvia targeting INR20 crores and Spinoace INR10 crores plus for FY27.

    • In-licensing products revenue increased from INR36 crores (Q1 FY26) to INR46 crores (Q1 FY27).

    • Kaeros is on track to grow at a CAGR of 100% initially, aiming to be a second growth platform.

    Concerns

    6
    • Revenue from operations degrew by 12% from INR691 crores to INR612 crores.

    • EBITDA degrew by around 20%, with EBITDA percentage down from 12.2% to 11.1%.

    • PAT margin decreased from 8.4% to 7.2%.

    • Patented products revenue decreased from INR97 crores to INR70 crores.

    • Volume degrowth was about 13% in Q1 FY27, with only 2% value growth.

    • Delayed and uneven monsoon, coupled with high temperatures, impacted sowing activity and delayed demand for crop protection products.

    Key financials

    Single quarter

    07 metrics
    1. 01Revenue from Operations₹612 Cr-12.9%YoY
    2. 02Gross Profit₹193.16 Cr-4.4%YoY
    3. 03Gross Profit %31.6%+9%YoY
    4. 04EBITDA %11.1%-9%YoY
    5. 05PAT Margin7.2%-14.3%YoY

    Segment breakdown

    B2C Sales (Q1 FY27)
    64% Share of Total Sales
    B2B Sales (Q1 FY27)
    34% Share of Total Sales
    Export Sales (Q1 FY27)
    2% Share of Total Sales
    B2C Insecticide Sales (Q1 FY27)
    33% Share of B2C Sales
    B2C Herbicide Sales (Q1 FY27)
    59% Share of B2C Sales
    B2C Fungicide Sales (Q1 FY27)
    5% Share of B2C Sales
    B2C PGR Sales (Q1 FY27)
    3% Share of B2C Sales
    In-licensing Products Revenue
    ₹46 Cr Revenue
    Patented Products Revenue
    ₹70 Cr Revenue
    Combination Products Revenue
    ₹98 Cr Revenue
    Newly Launched Products (Q1 FY27)
    ₹5.5 Cr Sales
    List

    Capital allocation

    1
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Guidance & targets

    12
    CategoryTargetPriority
    Product Mix
    Premium product contribution to sales
    70%
    High
    Growth
    Company size doubling
    double
    Medium
    New Product Development
    New products in pipeline for launch
    more than 30 products
    High
    Capex
    Annual maintenance capex
    INR30-40 crores
    High
    Capacity Expansion
    Sotanala formulation facility commencement
    commence
    High
    Capacity Expansion
    Sotanala technical production commencement
    commence
    High
    New Product Sales
    Granuvia sales
    INR20 crores
    Medium
    New Product Sales
    Spinoace sales
    INR10 crores plus
    Medium
    New Product Sales
    Total new products (Granuvia + Spinoace) net sales
    INR25 crores
    Medium
    Kaeros Growth
    Kaeros CAGR
    100%
    High
    Sales Returns
    Sales return numbers reduction
    at least half
    Medium
    Capacity Utilization
    Dahej technical production plant additional revenue
    INR200 crores
    Medium

    What to watch in Q2 FY27

    5

    Q2 Sales Performance & Recovery

    next quarter
    CurrentQ1 revenue degrowth of 12%
    TargetStronger execution and recovery in sales

    Why it matters

    To assess if the agricultural season normalizes and demand picks up as expected, driving revenue growth after a weak Q1.

    Looking ahead, while delayed monsoons impacted the first quarter, we believe the agriculture cycle has largely been deferred rather than lost. With rainfall improving, sowing progressing and crop protection activity normalizing, we expect stronger execution over the remaining three quarters.

    Risks & concerns

    4
    RiskSeverity

    Delayed and uneven monsoon

    Impacted Q1 sowing activity and delayed demand for crop protection products.Management acknowledged

    high

    Raw material price volatility

    Crude and petroleum-linked raw material costs remain a pressure area, with high fluctuations in solvent and plastic prices.Management acknowledged

    medium

    Elevated inventory levels

    June inventory was slightly elevated due to the slower start of the agricultural season, requiring focus on improving turns.Management acknowledged

    medium

    Limited pricing power due to weak demand

    Market sentiment was weak, preventing significant price hikes despite cost increases, impacting margins.Management acknowledged

    medium

    Q&A highlights

    8

    “It will be a project total investment. These total investment will go roughly about INR200 crores, out of which I think about INR50 crores will be going in the formulations and INR150 crores will be for the technical. And the total investment made so far is to the tune of about INR70 crores.”

    Provides specific financial allocation for the new Sotanala manufacturing facility, detailing investment in formulation vs. technical plants and current spend.

    asked by Prashant Biyani

    2 min read5 chapters

    Detailed Narrative

    01

    Q1 FY27 Performance Overview and Market Challenges

    Insecticides (India) Limited reported a challenging Q1 FY27, with revenue from operations degrowing by 12% from INR691 crores to INR612 crores. This was primarily attributed to an unusual agricultural season characterized by delayed and uneven monsoons and high temperatures, impacting sowing activity and demand. Despite the revenue decline, the gross profit percentage improved from 29% to 31.6%, though EBITDA and PAT margins saw a reduction to 11.1% and 7.2% respectively. Volume degrowth was approximately 13%, with value growth at 2%.

    02

    Strategic Product Mix and New Launches

    The company continues its focus on premiumization, with premium products contributing 64% of the total B2C business in Q1 FY27, up from 58% in Q1 FY26. The target is to increase this contribution to 70% in the next 3-4 years. New products like Granuvia and Spinoace, launched in collaboration with Corteva Agriscience, generated INR5.50 crores in Q1 FY27. Granuvia is expected to reach INR20 crores and Spinoace INR10 crores plus in sales for the full FY27, with total net sales from these two products projected at INR25 crores.

    03

    Manufacturing Capacity Expansion and Timelines

    The Sotanala project is progressing as planned, with a total estimated investment of INR200 crores, comprising INR50 crores for the formulation facility and INR150 crores for the technical plant. Approximately INR70 crores has been invested to date. The formulation facility at Sotanala is expected to commence operations around April-May next year, followed by technical production by Diwali. Additionally, investments in Udhampur for herbicide and insecticide plants are slated for completion this year, and the Dahej facility is over 70% commercialized.

    04

    R&D, Farmer Engagement, and Kaeros Growth

    The company maintains a strong focus on R&D and technology partnerships, with over 30 new products in the pipeline for launch within the next two years. Farmer engagement remains a priority, with over 3,600 farmer meetings, 600 field days, and 1,400 demonstrations conducted in Q1. Kaeros Research, a second growth platform, is targeting an initial CAGR of 100%, though its margins are currently in the single digits due to high initial expenses, including the hiring of 100 new personnel.

    05

    Working Capital Management and Efficiency Initiatives

    Working capital discipline is a key focus, especially given the slightly elevated inventory levels in June due to the slow start of the agricultural season. The company aims to improve inventory turns, collections, and align placement with underlying demand to reduce the working capital cycle. Efficiency initiatives, including the adoption of solar and wind energy and solid fuel, are being implemented to control expenses and improve ROCE and ROE.

    This is an AI-generated summary of a publicly available earnings call transcript.